Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat

British Journal of Pharmacology

Volumn 121, Issue 4, 1997, Pages 751-758

  Bourlon, P M ^a   Faure Dussert, A ^a   Billaudel, B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

cell; 1,25(OH)2D3; Cyclic AMP; Endocrine pancreas; Glucagon; Insulin release; Islet; Vitamin D3 deficiency

Indexed keywords

ADENYLATE CYCLASE; BARIUM; CALCITRIOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; GLUCAGON; INSULIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPERGLUCAGONEMIA; INSULIN RELEASE; INSULIN RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; NEWBORN; NONHUMAN; NUCLEOTIDE METABOLISM; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; VITAMIN D DEFICIENCY;

ANIMALS; BARIUM; CALCITRIOL; CHOLECALCIFEROL; CYCLIC AMP; INSULIN; ISLETS OF LANGERHANS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; THEOPHYLLINE;

EID: 0030919926     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701204     Document Type: Article

References (53)

1. ALLEN, D.O., CLARK, J.F. & ASHMORE, J. (1973). Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3′5′-adenosine monophosphate levels in isolated fat cells. J. Pharmacol. Exp. Ther., 185, 379-385.
2. ASHCROFT, F.M. & ASHCROFT, S.J.H. (1992). Mechanism of insulin secretion. In Insulin. ed. Ashcroft, F.M. & Ashcroft, S.J.H. pp. 97-150. Oxford, New York, Tokyo: Oxford University Press.
3. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phospho-diesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
4. 3 alters the effect of cAMP in thyroid cells by increasing the regulatory subunit type IIβ of the cAMP-dependent protein kinase. J. Biol. Chem., 269, 32233-32238.
5. 3 attenuates TSH and 8-(4-chloro-phenylthio)-cAMP-stimulated growth and iodide uptake by rat thyroid cells (FRTL-5). Thyroid, 3, 245-251.
6. 3 pretreatment. Diabète & Métabolisme, 15, 85-87.
7. 3-deprived rats. Am. J. Physiol., 258, E643-E648.
8. BILLAUDEL, B., LABRIJI-MESTAGHANMI, H., SUTTER, B.Ch.J. & MALAISSE, W.J. (1988). Vitamin D and pancreatic islet function. II. Dynamics of insulin release and cationic fluxes. J. Endocrinol. Invest., 11, 585-593.
9. 3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J. Endocrinol. Invest, 18, 673-682.
10. 3-deficient rats. Steroids, 58, 335-341.
11. BOUCHER, B.J., MANNAN, N., NOONAN, K., HALES, C.N. & EVANS, S.J. (1985). Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia, 38, 1239-1245.
12. 3. J. Endocrinol., 148, 223-232.
13. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
14. 45Ca efflux from perifused islets. Metabolism, 22, 455-465.
15. CHERTOW, B.S., SIVITZ, W.I. BARANETSKY, N.G., CLARK, S.A., WAITE, A. & DELUCA, H.F. (1983). Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology, 113, 1511-1517.
16. CHEUNG, W.Y (1970). Cyclic nucleotide phosphodiesterase. In Role of Cyclic AMP in Cell Function. Advances in Biochemical Psychopharmacology. Vol. 3, ed. Greengard, P. & Costa, E. pp. 51-65. New York: Raven Press.
17. CHIJIWA, T., MISHIMA, A., HAGIWARA, M., SANO, M., HAYASHI, K., INOUE, T., NAITO, K., TOSHIOKA, T. & HIDAKA, H. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocyotoma. J. Biol. Chem., 265, 5267-5272.
18. 3 in the pancreas. Cell Tissue Res., 209, 515-520.
19. DE BOLAND, A.R. & BOLAND, R.L. (1994). Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal, 6, 717-724.
20. FAURE, A., HAOUARI, M. & SUTTER, B.Ch.J. (1988). Short term and direct influence of oestradiol on glucagon secretion stimulated by arginine. Diabète & Métabolisme (Paris), 14, 452-454.
21. 3-deprived rats? Diabète & Métabolisme, 7, 271-278.
22. HENQUIN, J.C. (1985). The interplay between cyclic AMP and ions in the stimulus-secretion coupling in pancreatic β-cells. Arch. Int. Physiol. Biochem., 93, 37-48.
23. HERBERT, V., LAU, K.S., GOTTLIEB, C.W. & BLEICHER, S.J. (1965). Coated charcoal immunoassay of insulin. J. Clin. Endocrinol., 122, 1375-1384.
24. 3 in rat pancreas. Mol. Cell Endocrinol., 60, 109-117.
25. 3 administration. Endocrinology, 117, 1765-1771.
26. 3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes, 34, 315-320.
27. LABRIJI-MESTAGHANMI, H., BILLAUDEL, B., GARNIER, P.E., MALAISSE, W.J. & SUTTER, B.Ch.J. (1988). Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J. Endocrinol. Invest., 11, 577-584.
28. LACY, P.E. & KOSTIANOVSKY, M. (1967). Method for the isolation of intact islets of Langerhans from pancreas. Diabetes, 16, 35-39.
29. 3 of adenylate cyclase along the villus of chick duodenum. Endocrinology, 119, 2568-2573.
30. MALAISSE, W.J. (1973a). Insulin secretion: multifactorial regulation for a single process of release. Diabetologia, 9, 167-173.
31. MALAISSE, W.J. (1973b). Theophylline-induced translocation of calcium in the pancreatic beta cell: inhibition by deuterium oxide. Nature, New Biol., 242, 189-190.
32. MALAISSE, W.J. & MALAISSE-LAGAE, F. (1984). The role of cyclic AMP in insulin release. Experientia, 40, 1068-1075.
33. MORTENSEN, B.M., LUND, H.W., JABLONSKY, G., PAULSSEN, R.H. & GORDELADZE, J.O. (1995). Direct effects of vitamin D-3 analogues on G-protein mediated signalling systems in rat osteosarcoma cells and rat pituitary adenoma cells. Bioscience Rep., 15, 135-150.
34. 2′-Dibutyryl cyclic AMP and its possible involvement in the action of cyclic AMP derivatives in vivo. J. Biochem., 85, 1321-1329.
35. PIPELEERS, D.G., SCHUIT, F.C., IN'T VELD, P.A., MAES, E., HOOGHE-PETERS, E.L., VAN DE WINKEL, M. & GEPT, S. (1985). Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology, 117, 824-833.
36. PORTHA, B. (1991). Physiology of the pancreatic β-cell. Med. Sci., 7, 212-225.
37. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev., 67, 1185-1248.
38. RAGHURAMULU, N., RAGHUNATH, M., CHANDRA, S., SAHAY, K.B. & GUPTA, C. (1992). Vitamin D improves oral glucose tolerance and insulin secretion in human diabetes. J. Clin. Biochem. Nutr., 13, 45-51.
39. ROHNER-JEANRENAUD, F. & JEANRENAUD, B. (1984). Oversecretion of glucagon by pancreases of ventromedial hypothalamic-lesioned rats: a revaluation of a controversial topic. Diabetologia, 27, 535-539.
40. SCHUIT, F.C. & PIPELEERS, D.G. (1985). Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology, 117, 834-840.
41. SENER, A. & MALAISSE, W.J. (1979). The stimulus-secretion coupling of glucose-induced insulin release. Metabolic events in islets stimulated by non-metabolizable secretagogues. Eur. J. Biochem., 98, 141-147.
42. SHARP, G.W. (1979). The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia, 16, 287-296.
43. SHARP, R., CULBERT, S., COOK, J., JENNINGS, A. & BURR, I.M. (1974). Cholinergic modulation of glucose-induced biphasic insulin release in vitro. J. Clin. Invest., 53, 710-716.
44. 1) cells. Mol. Cell. Endocrinol., 101, 183-188.
45. 3 identified by thaw-mount autoradiography. In Hormone Control of Calcium Metabolism. Vol 6. ed. Cohn, D.V., Taladge, R.V. & Matthews, J. pp. 222-229. Amsterdam: Excerpta Medica.
46. SUGDEN, M.C. CHRISTIE, M.R. & ASHCROFT, S.J.H. (1979). Presence and possible role of calcium-dependent regulator (calmodulin) in rat islets of Langerhans. FEBS Lett., 105, 95-100.
47. THOMPSON, W.J. & APPLEMAN, M.M. (1971). Characterization of cyclic nucleotide phosphodiesterase of rat tissues. J. Biol. Chem., 246, 3145-3150.
48. TOURNIER, S., GERBAUD, P., ANDERSON, W.B., LOHMANN, S.M., EVAIN-BRION, D. & RAYNAUD, F. (1995). Post-translational abnormality of the type II cyclic AMP-dependent protein kinase in psoriasis: modulation by retinoic acid. J. Cell Biochem., 57, 647-654.
49. VALVERDE, I. & MALAISSE, W.J. (1984). Calmodulin and pancreatic B-cell function. Experientia, 40, 1061-1068.
50. WALTERS, M.R. (1992). Newly identified actions of the vitamin D endocrine system. Endocrine Rev., 13, 719-764.
51. 2+, cAMP and diacylglycerol. Mol. Cell Endocrinol., 70, 119-137.
52. ZAWALICH, W.S. & ZAWALICH, K.C. (1990). Forskolin-induced desensitization of pancreatic β-cell insulin secretory responsiveness: possible involvement of impaired information flow in the inositol-lipid cycle. Endocrinology, 126, 2307-2312.
53. ZAWALICH, W.S. & ZAWALICH, K.C. (1996). Glucagon-like peptide-1 stimulates insulin secretion hut not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol. Metabolism, 45, 273-278.